logo

For the Inventor, By the Inventor

Boston, MA, United States of America

Emulate, Inc.


USPTO Granted Patents = 77

% Expired Patents = 3.9



Trademarks = 14

Forward Citations = 155

Loading Chart...
Loading Chart...

71 inventors (with patents filed for the assignee):

goldMedal Daniel Levner (50 out of 103 patents)

silverMedal Christopher David Hinojosa (45 out of 66 patents)

bronzeMedal Norman Wen (30 out of 35 patents)

4.  Geraldine A Hamilton (25 out of 35 patents)

5.  S Jordan Kerns (24 out of 24 patents)

6.  Antonio Varone (23 out of 26 patents)

7.  Josiah Daniel Sliz (22 out of 26 patents)

8.  Joshua Gomes (22 out of 29 patents)

9.  Jacob Fraser (18 out of 18 patents)

10.  Catherine Karalis (17 out of 17 patents)

11.  Guy Robert Thompson, Ii (16 out of 20 patents)

12.  Kyung Jin Jang (13 out of 13 patents)

13.  Riccardo Barrile (12 out of 13 patents)

14.  Justin Nguyen (10 out of 13 patents)

15.  Lewis Rowe (10 out of 10 patents)


Core Competencies:
Microfluidic Chip
Organ-On-Chip
Cell Growth
Intestinal Cells
Bubble Removal
Pressure Control
Cancer Invasion
Tissue Culture
Epithelial Models
Fluid Perfusion
Blood Brain Barrier
Spinal Cord Development

77 patents:

1. 12397291 - Removing bubbles in a microfluidic device (2025-08-26),
2. 12378528 - Systems and methods for growth of intestinal cells in microfluidic devices (2025-08-05),
3. 12378519 - Microfluidic model of the blood brain barrier (2025-08-05),
4. 12298320 - Compound distribution in microfluidic devices (2025-05-13),
5. 12209253 - Development of spinal cord on a microfluidic chip (2025-01-28),
6. 12098356 - Effects of space travel on human brain cells (2024-09-24),
7. 12098352 - Stem cell-based lung-on-chip models (2024-09-24),
8. 12091650 - Development of spinal cord on a microfluidic chip (2024-09-17),
9. 12070746 - Method of osteogenic differentiation in microfluidic tissue culture systems (2024-08-27),
10. 12036548 - Organs-on-chips as a platform for epigenetics discovery (2024-07-16),
11. 12019083 - Compound distribution in microfluidic devices (2024-06-25),
12. 12018284 - Physiology and pathophysiology of human gut: intestine-on-chip (2024-06-25),
13. 11999932 - Microfluidic control (2024-06-04),
14. 11970680 - Devices, systems and methods for inhibiting invasion and metasases of cancer (2024-04-30),
15. 11952592 - Systems and methods for growth of intestinal cells in microfluidic devices (2024-04-09),
Company Overview
Emulate, Inc. is a pioneering company based in Boston, MA, specializing in microfluidic devices that replicate human organ functions. The company focuses on developing organ-on-chip technology, which allows for advanced modeling of human biology and disease. This innovative approach supports research in areas such as cancer invasion and tissue culture, facilitating breakthroughs in drug development and personalized medicine. Emulate's solutions enhance the understanding of cellular interactions and improve experimental accuracy in biomedical research.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

Emulate, Inc. USPTO Patent Assignee Logo
77 Patents

#33 in Boston, MA

#264 in Massachusetts

#4,788 in US

#9,777 in the World

Boston, MA (US)
Boston, MA, United States of America

Emulate, Inc.

Forward Citations = 155

71 inventors:

goldMedal Daniel Levner (50 out of 103 patents)

silverMedal Christopher David Hinojosa (45 out of 66 patents)

bronzeMedal Norman Wen (30 out of 35 patents)

4.  Geraldine A Hamilton (25 out of 35 patents)

5.  S Jordan Kerns (24 out of 24 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Emulate, Inc.. Retrieved from https://idiyas.com/company/emulate

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…